Injecting rabies immunoglobulin (RIG) into wounds only: A significant saving of lives and costly RIG-Reference-Cited by-同舟云学术

Injecting rabies immunoglobulin (RIG) into wounds only: A significant saving of lives and costly RIG

Published:2017-02-22 Issue:4 Volume:13 Page:762-765
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Bharti Omesh Kumar¹^ORCID,Madhusudana Shampur Narayan²^ORCID,Wilde Henry³

Affiliation:

1. State Intra-dermal Anti-rabies Clinic and Research Centre, DDU Zonal Hospital Shimla, Government of Himachal Pradesh, Shimla, India

2. Department of Neurovirology, WHO-Collaborating Centre for Reference and Research on Rabies, NIMHANS, Bangalore, India

3. WHO- Collaborating Centre for Research and Training on Zoonoses, Faculty of Medicine and King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2016.1255834

Reference15 articles.

1. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey

2. WHO, Expert Consultation on Rabies. Technical Report Series 982. 2012, Geneva: WHO.

3. Human rabies: neuropathogenesis, diagnosis, and management

4. Worldwide rabies deaths prevention—A focus on the current inadequacies in postexposure prophylaxis of animal bite victims

5. The incurable wound revisited: progress in human rabies prevention?

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influencing factors and prediction of neutralizing antibodies in post-exposure rabies vaccine recipients;Heliyon;2024-08

2. Plant Molecular Pharming to Overcome the Global Impact of Neglected Tropical Diseases;Concepts and Strategies in Plant Sciences;2024

3. Evaluating the benefit of serology during potential Australian bat lyssavirus and rabies post-exposure prophylaxis;Australian and New Zealand Journal of Public Health;2023-12

4. Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial;International Journal of Infectious Diseases;2023-09

5. Comparative Neutralization Activity of Commercial Rabies Immunoglobulin against Diverse Lyssaviruses;Vaccines;2023-07-18